Clin2
NCT07184385Possibly a fitNot yet recruiting

Umbilical cord blood infusion for long COVID

Long COVIDPost-COVID-19 ConditionPost-COVID SyndromePost-COVID Condition

Part of Infections, Lungs & breathing clinical trials.

This trial tests whether an infusion made from human umbilical cord blood can help people with long COVID (also called post-COVID condition) feel better. It may reduce symptoms by supporting the immune system, though more research is needed.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have been diagnosed with post-COVID condition (long COVID).
  • You must have had a negative COVID-19 test (PCR or antigen) within the last 7 days.
  • You must be willing to come to study visits and follow all study instructions.
  • You cannot be pregnant, breastfeeding, or planning to get vaccinated during the treatment period.
  • You must not have other serious health conditions like neurological disorders, terminal illness, or immune diseases.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07332338AVAILABLE
Umbilical cord blood infusion for long COVID fatigue

This trial offers an experimental treatment using umbilical cord blood cells to help people with chronic fatigue from long COVID. The goal is to see if this infusion can reduce fatigue and improve quality of life.

Miami, Florida
NCT07316127Recruiting· Phase 2
Blood filtering for autoimmune long COVID

This trial tests if filtering certain antibodies from the blood can help people with long COVID who experience post-exertional malaise (PEM) and reduced function. It aims to see if this treatment reduces symptoms and improves daily life.

Amsterdam
NCT06992401Not yet recruiting
Nasal immunoglobulin for long covid with immune problems

This study tests whether giving a nasal spray of immunoglobulin (antibodies) helps people with long covid who also have a weakened immune system. It may improve symptoms like fatigue or brain fog.

NCT07597902Not yet recruiting· Phase 2
Antiviral treatment for long covid symptoms

This study tests whether a combination of antiviral medications can help reduce Long COVID symptoms by targeting viruses that may stay in the body. If you have Long COVID, this treatment might help you feel better.

New York, New York
NCT07397910Not yet recruiting
Natural compound for long covid inflammation

This trial tests a natural compound to help reduce long-term inflammation in people who still have symptoms after a COVID-19 infection. If you're struggling with ongoing symptoms like fatigue or brain fog after COVID-19, this might be worth exploring.

Murcia
NCT06928272Recruiting· Phase 3
Long COVID drug study for adults 18 to 65

This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.

San Diego, California

Hear when a new Long COVID trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.